Need professional-grade analysis? Visit stockanalysis.com
$13.28B
17.10
4,003
2.47%
Guobang Pharma Ltd (605507) trades on SHG in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at CNY24.03, down 0.91% from the previous close.
Over the past year, 605507 has traded between a low of CNY18.48 and a high of CNY29.25. The stock has gained 28.0% over this period. It is currently 17.8% below its 52-week high.
Guobang Pharma Ltd has a market capitalization of $13.28B, with a price-to-earnings ratio of 17.10 and a dividend yield of 2.47%.
Guobang Pharma Ltd. engages in the research, development, production, and sale of products in the pharmaceutical and veterinary industries. The company offers pharmaceutical products, including quinolones, macrolides, cephalosporins, characteristic APIs, preparations and accessories, and key pharmaceutical intermediates; and mobile protection APIs, kinetophoretic preparations, and feed additives. It sells its products approximately in 117 countries and regions worldwide. The company was founded in 1996 and is based in Xinchang, China.
Side-by-side comparison against top Healthcare peers.